论文部分内容阅读
目的:分析儿科呼吸系统疾病行盐酸氨溴索药物注射液的临床效果。方法:将我院2011年8月-2014年10月接受儿科呼吸系统疾病患儿80例,分成两组行不同疗法,即:对照组(布地奈德疗法)、研究组(盐酸氨溴索疗法),预后评估总体效果。结果:研究组预后病症缓解37例,缓解率为92.5%,和对照组75.0%相比较高,有区别(P<0.05)。结论:临床针对儿科呼吸系统疾病患儿行盐酸氨溴索注射液疗法作用显著,值得借鉴。
Objective: To analyze the clinical effect of ambroxol hydrochloride injection on pediatric respiratory diseases. Methods: Eighty children with pediatric respiratory diseases were admitted to our hospital from August 2011 to October 2014 and divided into two groups with different therapies, namely control group (budesonide therapy), study group (ambroxol hydrochloride therapy ), Prognosis to assess the overall effect. Results: The prognosis of study group was relieved in 37 cases, the remission rate was 92.5%, which was significantly higher than that of the control group (75.0%) (P <0.05). Conclusion: The clinical effect of ambroxol hydrochloride injection in children with pediatric respiratory diseases is significant and worth learning from.